Study Stopped
The financial support was withdrawn.
Calcium Dobesilate for Chronic Venous Wounds
Randomized, Double-blind Multicenter Clinical Trial Comparing the Efficacy of Calcium Dobesilate With Placebo in the Treatment of Ulcer Secondaries to Chronic Venous Disease
1 other identifier
interventional
230
1 country
42
Brief Summary
The objective of the study is to assess the efficacy of calcium dobesilate for treating chronic venous wounds. The hypothesis is that venous ulcers treated with standards measures (compressive measures) and calcium dobesilate will heal-up better than venous ulcers treated with standards measures (compressive measures) and placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
42 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 17, 2009
CompletedFirst Posted
Study publicly available on registry
September 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedFebruary 17, 2011
February 1, 2011
2.2 years
September 17, 2009
February 16, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Healed venous ulcers
at 6 months of treatment
Secondary Outcomes (5)
Percentage of re-epithelization area (cm2)
at 6 month of treatment
Length of time to heal ulcers
during all the period of the study (12 months)
Ulcer recurrence
at 12 month
Ulcer pain
at 6 and 12 months
Safety
during the study (12 months)
Study Arms (2)
Calcium Dobesilate
EXPERIMENTALPlacebo
PLACEBO COMPARATORThe placebo is a capsule with the same presence of experimental drug.
Interventions
500 mg/ three times/day for 6 months (capsules)
Eligibility Criteria
You may qualify if:
- Patients with venous ulcer (CEAP 6) that affect epidermis, dermis and/or subcutaneous tissue, with and area superior to 3 cm2
- Ankle-arm index 0.9 or superior
- Written informed consent of the patients
You may not qualify if:
- Patients with venous ulcer (CEAP 6) that affect bone or with and area inferior to 3 cm2
- Ankle-arm index inferior to 0.9
- No written informed consent of the patients
- Diabetes mellitus I y II
- Patients with renal failure and dialysis
- Vascular surgery needed
- Impossibility to use compressive measures on the leg
- Use of topic antibiotics, silver dressing, growth factors, plasma-rich in platelets, skin graft, pentoxifylline, ultrasounds, laser, hyperbaric oxygen, electric stimulation o vacuum.
- Pregnancy
- Breast feeding
- No anticonceptives measures
- Allergy or intolerance to phebotonics
- Background of neutropenia or leucopenia
- Basal leucocytes \< 3.500/ml
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacion Iberoamericana Itacalead
- Esteve Pharmaceuticals, S.A.collaborator
Study Sites (42)
Hospital General de Albacete
Albacete, Albacete, 02006, Spain
Hospital Germans Tries i Pujol
Badalona, Barcelona, 08916, Spain
CAP Joanic
Barcelona, Barcelona, 08025, Spain
Hospital Sant Jaume de Calella
Calella, Barcelona, 08370, Spain
CAP El Castell
Castelldefels, Barcelona, 08660, Spain
Hospital General de Granollers
Granollers, Barcelona, 08402, Spain
Consorci Hospitalari de Mataró
Mataró, Barcelona, 08304, Spain
CAP Pineda de Mar
Pineda de Mar, Barcelona, 08397, Spain
Corpotació Sanitària Parc Taulí
Sabadell, Barcelona, 08208, Spain
CAP Sitges
Sitges, Barcelona, 08870, Spain
CAP El Remei
Vic, Barcelona, 08500, Spain
Hospital de Vic
Vic, Barcelona, 08500, Spain
CAP Doctor Guillermo Masriera i Guardiola
Vilassar de Mar, Barcelona, 08340, Spain
CAP Les Corts
Barcelona, Catalonia, 08015, Spain
CAP Gaudí
Barcelona, Catalonia, 08025, Spain
CAP Sagrada Familia
Barcelona, Catalonia, 08025, Spain
CAP Vila de Gràcia
Barcelona, Catalonia, 08025, Spain
EAP Sardenya
Barcelona, Catalonia, 08025, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, 08025, Spain
Hospital Dos de Maig
Barcelona, Catalonia, 08025, Spain
CAP la Sagrera
Barcelona, Catalonia, 08027, Spain
CAPSE
Barcelona, Catalonia, 08036, Spain
ABS Encants
Barcelona, Catalonia, 08041, Spain
ABS Lesseps
Barcelona, Catalonia, 902011040, Spain
CAP la Salut
Barcelona, Catalonia, 902011040, Spain
CAP Barceloneta
Barcelona, Catalonia, Spain
CAP Vila Olímpica
Barcelona, Catalonia, Spain
CAP Albera Salut
Peralada, Girona, 17491, Spain
Hospital de Leon
León, Leon, 24071, Spain
Fundación Hospital de Alcorcón
Alcorcón, Madrid, 28922, Spain
Hospital de Getafe
Getafe, Madrid, 28905, Spain
Complejo Hospitalario de Son Dureta
Mallorca, Mallorca, 07014, Spain
Hospital de Cabueñes
Gijón, Principality of Asturias, 33394, Spain
Hospital Central de Asturias
Oviedo, Principality of Asturias, 33006, Spain
Hospital Sant Joan de Reus
Reus, Tarragona, 43201, Spain
CAP Vila-Rodona
Vilarrodona, Tarragona, 43814, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47005, Spain
Hospital Platon
Barcelona, Spain
Hospital Virgen de las Nieves
Granada, 18014, Spain
Hospital San Pedro de Logroño
Logroño, 26006, Spain
Hospital la Princesa
Madrid, 28005, Spain
Hospital Clínico Universitario San Carlos
Madrid, 28905, Spain
Related Publications (1)
Martinez-Zapata MJ, Vernooij RW, Simancas-Racines D, Uriona Tuma SM, Stein AT, Moreno Carriles RMM, Vargas E, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD003229. doi: 10.1002/14651858.CD003229.pub4.
PMID: 33141449DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moreno Carriles, Rosa Mª
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 17, 2009
First Posted
September 18, 2009
Study Start
April 1, 2008
Primary Completion
July 1, 2010
Last Updated
February 17, 2011
Record last verified: 2011-02